https://clinicaltrials.gov/ct2/show/NCT03656562?type=Intr&cond=Lupus&phase=012345&lupd_s=01%2F23%2F2019&lupd_d=14
Condition : Systemic Lupus Erythematosus (SLE)
Interventions : Drug: VAY736; Drug: VAY736 Placebo; Drug: CFZ533; Drug: CFZ533 Placebo
Sponsor : Novartis Pharmaceuticals
Recruiting
Study the Efficacy and Safety of VAY736 and CFZ533 in SLE Patients
NCT03656562
Mon, 03 Sep 2018 12:00:00 EDT
